异甘草酸镁治疗慢性乙型肝炎临床疗效观察

Abstract

Abstract: Objective To observe the clinical efficacy of magnesium isoglycyrrhizinate in the treatment of patients with chronic hepatitis B. Methods The 81 patients with chronic hepatitis B were treated with 150mg magnesium isoglycyrrhizinate and 65 were treated with 80ml compound isoglycyrrhizinate for 4 weeks. Symptoms,signs and hepatic function tests were observed. Results The level of ALT dropped more rapidly in magnesium isoglycyrrhizinate-treated patients than that in control group; There was no obvious side effects in magnesium isoglycyrrhizinate group,while there was 2 cases with side effects in control group. Conclusions Clinic symptom and liver function tests improve after treatment with magnesium isoglycyrrhizinate in patients with chronic hepatitis B.

Key words: [Key words] Hepatitis B, Magnesium isoglycyrrhizinate, Compound isoglycyrrhizinate, Therapy

WU Yichen, LI Qiuzhen, LIU Hongling, et al.. Clinical observation of magnesium isoglycyrrhizinate in the treatment of patients with chronic hepatitis B[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(1): 34-36.

References

[1] 张喜全,夏春光,万顺之. 天晴甘美[J]. 中国新药杂志,2006,15（16）：1409.
[2] 王佩,吴锡铭. 异甘草酸镁对大鼠四氯化碳慢性肝损伤的治疗作用[J]. 中国新药与临床杂志,2004,23（12）：833-835.
[3] 田静,吕坚. 18α-甘草酸和18β-甘草酸抗大鼠肝纤维化作用比较研究实验[J]. 中国现代应用药学,2006,23（2）：102-104.
[4] 王慧芬,苏海滨,刘鸿凌,等. 甘草酸二铵治疗各类肝病629例临床观察[J]. 中华传染病杂志,2004,22（2）：113-115.
[5] 李永新,高庆伟,DIANA ML,等. 硫胺素与甘草酸二铵治疗慢性乙型肝炎的临床疗效分析[J]. 临床肝胆病杂志,2003,19（4）：226-227.
[6] 谢杏榕,占国清,邓文钦,等. 酚妥拉明联合甘利欣治疗慢性重型肝炎的临床研究[J]. 临床肝胆病杂志,2004,20（6）：351-352.
[7] TANDON A,TANDON B N,BHUJWALA R A. Clinical spectrum of acute sporadic hepatitis E and possible benefit of glycyrrhizin therapy[J]. Hepatol Res,2002,23：25.
[8] 沈金芳,逢晓云,孙黎. 异甘草酸镁注射液人体内药动学研究[J]. 中国药学杂志,2005,10：769-771.
[9] 姚晓东,沈金芳,茅益民,等. 慢性肝病患者单剂量静脉滴注异甘草酸镁药代动力学研究[J]. 上海交通大学学报（医学版）,2009,29（2）：177-180.
[10] 陈蔚华,陆伦根,曾明德,等. 异甘草酸镁对大鼠肝星状细胞增殖和氧应激的影响[J]. 中华肝脏病杂志,2006,14（6）：426-430.
[11] 董丽萍,于锋,柳静,等. 异甘草酸镁对D-氨基半乳糖急性肝损伤模型小鼠的保护作用研究[J]. 中国药房,2006,17（12）：902-904.
[12] 陈组武,于榕,鲁映青,等. 异甘草酸对家兔内毒素休克的防治作用[J]. 中国临床药学杂志,2006,15（3）：160-163.
[13] 曾春香,杨晴,胡琴. 异甘草酸镁与复方甘草酸苷在大鼠体内分布和代谢的比较研究[J]. 中国药房,2006,17（20）：1543-1545.

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.

Clinical observation of magnesium isoglycyrrhizinate in the treatment of patients with chronic hepatitis B

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments